An Open-label Study of Serum Testosterone Levels in Non-dosed Females After Secondary Exposure to Testosterone Gel 1.62%.
Phase of Trial: Phase I
Latest Information Update: 28 Apr 2010
At a glance
- Drugs Testosterone (Primary)
- Indications Hypogonadism
- Focus Pharmacokinetics
- Sponsors Solvay Pharmaceuticals
- 09 Dec 2009 Actual end date (Oct 2009) added as reported by ClinicalTrials.gov.
- 09 Dec 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 31 Oct 2009 New trial record